Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by DryBoneson Apr 01, 2019 9:41pm
218 Views
Post# 29567270

Despite the gloom there were a couple of good things...

Despite the gloom there were a couple of good things...1.  Thomvest knew all of this weeks ago yet put up more money to keep it going.

2. PPPS showed an increase in revenue that was pretty good.  $22 million annually and more business on the way.  I would value the PPPS busiess at $100 to 150 milion.  5 to 7 times revenue.
Under proper management or new owners it could do really, really well.

3.  Another director who shared responsibiity for this shtshow has left.  Yay.

Anyone else with any good points?
Bullboard Posts